Skip to main content
Clinical Trials/DRKS00017627
DRKS00017627
Recruiting
Not Applicable

Pilot study to evaluate the significance of detection of mutated, free circulating tumor DNA in adult patients with RAS wild-type and mutant colorectal cancer - ARTUR

IVERSITÄTSKLINIKUM Freiburg - Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation0 sites50 target enrollmentJuly 10, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C18
Sponsor
IVERSITÄTSKLINIKUM Freiburg - Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
IVERSITÄTSKLINIKUM Freiburg - Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation

Eligibility Criteria

Inclusion Criteria

  • 1\. Histologically confirmed colorectal cancer
  • 2\. Localized or metastatic disease
  • 3\. Primary diagnosis or relapse or progression
  • 4\. Tissue sample available for mutation analysis at screening

Exclusion Criteria

  • Other malignancies within the past 3 years except for adequately treated carcinoma of the cervix and basal or squamous cell carcinoma of the skin

Outcomes

Primary Outcomes

Not specified

Similar Trials